Extra-mucosal enucleation is still a safe and feasible treatment option of giant esophageal leiomyomas

Indian J Gastroenterol. 2018 Jan;37(1):63-66. doi: 10.1007/s12664-018-0835-z. Epub 2018 Feb 21.

Abstract

Esophageal leiomyoma (EL) is rare but still the most common benign tumor of the esophagus. Extra-mucosal enucleation (EME) is the treatment of choice. Many recent reports have favored esophageal resection for giant Esophageal leiomyomas (ELs). The consequence of esophageal resection is well known and it would be radical to consider it as a preferred treatment for giant EL since most of them are still benign. We share case series of five giant ELs managed by EME, avoiding a mucosal breach and hence avoiding potentially morbid esophageal resections.

Keywords: Esophageal leiomyoma; Extra-mucosal enucleation; Giant esophageal leiomyoma.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Endoscopic Mucosal Resection / methods*
  • Esophageal Mucosa / surgery*
  • Esophageal Neoplasms / diagnostic imaging
  • Esophageal Neoplasms / pathology
  • Esophageal Neoplasms / surgery*
  • Esophagectomy / methods*
  • Feasibility Studies
  • Humans
  • Leiomyoma / diagnostic imaging
  • Leiomyoma / pathology
  • Leiomyoma / surgery*
  • Male
  • Treatment Outcome
  • Young Adult